SAT-165 - Lack of Osteopontin promotes non-alcoholic steatohepatitis (NASH) and fibrosis, but protects against hepatocellular carcinoma (HCC) progression and mortality in a NASH-HCC mouse model
Autor: | Nardo, A.D., Grün, N.G., Zeyda, M., Oberhuber, G., Dumanic, M., Helbich, T., Stulnig, T.M. |
---|---|
Zdroj: | In Journal of Hepatology April 2018 68 Supplement 1:S680-S681 |
Databáze: | ScienceDirect |
Externí odkaz: |